News

MIRA Pharmaceuticals, Inc. (MIRA) News & Info.

By ThinkSabio

#ThinkSabio Latest News

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025

By ThinkSabio

Related Post

News

Estrella Immunopharma, Inc. (ESLA) Description, Stock price, News & Info.

ThinkSabio
News

Nuburu, Inc. (BURU) Description, Stock price, News & Info.

ThinkSabio
News

NexPoint Diversified Real Estate Trust (NXDT) Description, Stock price, News & Info.

ThinkSabio

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-GRND.WS (21-FEB-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-CVI (21-FEB-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-EWTX (21-FEB-2025)

SEC 13D/G

ThinkSabio-Stocks-Simplified-SEC-Update-OMER (21-FEB-2025)